Publicaciones en colaboración con investigadores/as de Centro Nacional de Biotecnología (28)

2023

  1. N′-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile

    Journal of Medicinal Chemistry, Vol. 66, Núm. 8, pp. 5465-5483

2022

  1. IQM-PC332, a Novel DREAM Ligand with Antinociceptive Effect on Peripheral Nerve Injury-Induced Pain

    International Journal of Molecular Sciences, Vol. 23, Núm. 4

  2. Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory response

    Journal of Pathology, Vol. 258, Núm. 3, pp. 312-324

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2019

  1. A Neutrophil Timer Coordinates Immune Defense and Vascular Protection

    Immunity, Vol. 50, Núm. 2, pp. 390-402.e10

  2. Identification of IQM-266, a novel DREAM ligand that modulates KV4 currents

    Frontiers in Molecular Neuroscience, Vol. 12

2013

  1. ISG15 Regulates Peritoneal Macrophages Functionality against Viral Infection

    PLoS Pathogens, Vol. 9, Núm. 10

2012

  1. Ca2+-activated nucleotidase 1, a novel target gene for the transcriptional repressor DREAM (Downstream Regulatory Element Antagonist Modulator), is involved in protein folding and degradation

    Journal of Biological Chemistry, Vol. 287, Núm. 22, pp. 18478-18491

  2. Reduced Mid1 expression and delayed neuromotor development in daDREAM transgenic mice

    Frontiers in Molecular Neuroscience

2011

  1. LC8 dynein light chain (DYNLL1) binds to the C-terminal domain of ATM-interacting protein (ATMIN/ASCIZ) and regulates its subcellular localization

    Biochemical and Biophysical Research Communications, Vol. 414, Núm. 3, pp. 493-498

2010

  1. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

    Molecular Cancer, Vol. 9

  2. Structural basis for the interaction between dynein light chain 1 and the glutamate channel homolog GRINL1A

    FEBS Journal, Vol. 277, Núm. 10, pp. 2340-2350

  3. Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tau

    Journal of Biological Chemistry, Vol. 285, Núm. 42, pp. 32539-32548

2008

  1. Ca2+-operated transcriptional networks: Molecular mechanisms and in vivo models

    Physiological Reviews, Vol. 88, Núm. 2, pp. 421-449

  2. Deciphering the genetic determinants for aerobic nicotinic acid degradation: The nic cluster from Pseudomonas putida KT2440

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Núm. 32, pp. 11329-11334

  3. Reply to Behrman: "N-Formylmaleamic acid: An intermediate in nicotinic acid metabolism"

    Proceedings of the National Academy of Sciences of the United States of America

  4. Synaptic terminals from mice midbrain exhibit functional P2X7 receptor

    Neuroscience, Vol. 151, Núm. 2, pp. 361-373

2007

  1. Existence of high and low affinity dinucleotides pentaphosphate-induced calcium responses in individual synaptic terminals and lack of correlation with the distribution of P2X1-7 subunits

    Neurochemistry International, Vol. 50, Núm. 4, pp. 628-641

  2. NMR Investigations of Lectin-Carbohydrate Interactions

    Lectins: Analytical Technologies (Elsevier), pp. 51-73

  3. Searching for a role of NCX/NCKX exchangers in neurodegeneration

    Molecular Neurobiology, Vol. 35, Núm. 2, pp. 195-202